FDA's digital health chief confirms generative AI regulatory guidance is imminent

FDA promises forthcoming guidance on generative AI medical devices, signaling regulatory clarity for developers of AI-driven healthcare technologies. Rick Abramson, head of digital health policy at the FDA, stated that the agency expects to issue regulatory guidance on policies regarding...